Serum lipid management in patients with type 1 and type 2 diabetes: a hospital-based cohort study

Diabetology International
Yukiko HasegawaYasuko Uchigata

Abstract

Serum lipid management is important for patients with diabetes; however, it has not been examined in our specialized diabetes clinic. The aim of the study was to assess the percentage of patients who did not achieve management targets (MT) for low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C) and triglycerides (TG), and explore factors related to failure to achieve lipid MT in Japanese patients with type 1 (T1D) and type 2 diabetes (T2D). This cross-sectional study included 795 patients (35% men) with T1D and 4018 patients (60% men) with T2D attending our diabetes center. MTs for serum lipids were in accordance with the guidelines of the Japan Atherosclerosis Society. Logistic regression analysis was performed to identify factors related to failure to achieve MTs for serum lipids. The percentages of men/women who did not achieve MT for LDL-C were 34.1/31.8% in T1D and 40.5/52.7% in T2D. The corresponding values for TG were 35.1/14.0% in T1D and 50.1/47.9% in T2D, and for HDL-C were 2.5/0% in T1D and 8.6/2.9% in T2D. Increase in body mass index (BMI) and glycated hemoglobin (HbA1c) were significantly and independently associated with failure to achieve lipid MT in patients with T1D and T2D...Continue Reading

References

Feb 28, 2001·American Journal of Epidemiology·H IsoY Komachi
Jan 25, 2003·Journal of Internal Medicine·T OkamuraUNKNOWN Nippon Data80 Research Group
Jan 15, 2008·Lancet·UNKNOWN Cholesterol Treatment Trialists' (CTT) CollaboratorsC Baigent
Aug 30, 2008·Endocrine Journal·Keiko AraiUNKNOWN Japan Diabetes Clinical Data Management Study Group
Jan 29, 2010·Diabetes Care·UNKNOWN American Diabetes Association
Mar 17, 2010·The New England Journal of Medicine·Henry N GinsbergRobert P Byington
Apr 28, 2012·Geriatrics & Gerontology International·Atsushi ArakiUNKNOWN Japanese Elderly Intervention Trial Research Group
May 6, 2014·The American Journal of Cardiology·Zahid Ahmad
Sep 17, 2014·JAMA : the Journal of the American Medical Association·Timo E StrandbergAlpo Vuorio
Feb 16, 2016·Journal of Atherosclerosis and Thrombosis·Hayato Tada, Junji Kobayashi
Apr 14, 2017·Diabetology & Metabolic Syndrome·Marília Izar Helfenstein FonsecaSandra Roberta G Ferreira
Dec 10, 2017·Diabetes Care·UNKNOWN American Diabetes Association
Mar 31, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Satoshi YamasakiHiromi Iwasaki

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.